RESUMEN
In the original publication [...].
RESUMEN
We investigated whether prior use of antibiotics affects the risk of mecillinam/trimethoprim/nitrofurantoin/multi-resistant Escherichia coli urinary tract infection (UTI) among elderly patients in general practice. Data on urine culture came from urine samples performed in general practice and sent to hospitals in the Capital Region of Denmark, and prescription data came from a nationwide prescription database. The study population consisted of patients with UTI episodes (n = 41,027) caused by E. coli that received a concurrent antibiotic prescription against UTI from 2012 to 2017. We used a case-control design. Cases were UTI episodes caused by mecillinam, trimethoprim, nitrofurantoin or multi-resistant E. coli and controls were UTI episodes caused by E. coli not displaying the respective resistance pattern. We analyzed whether exposure to antibiotics in a period of 8-90 days prior to the UTI episode affected the risk of antibiotic resistant uropathogenic E coli. The analyses were adjusted for age, sex, hospital admission and nursing home status. The odds of resistance to all of the four antibiotics increased significantly after exposure to antibiotics within 90 days prior to the UTI episode. In general, mecillinam showed the lowest increase in the odds for selection of resistance. The results indicate that mecillinam is a favorable antibiotic choice in terms of selection of resistance.
RESUMEN
AIMS: The development of effective interventions to reduce inappropriate use of antibiotics in the elderly population requires knowledge on who can benefit from such interventions. Thus, we aimed to identify and characterise antibiotic heavy users among elderly patients in general practice with respect to sociodemographic variables. METHODS: We conducted a retrospective nationwide register-based study on all Danish elderly citizens (⩾65 years) who redeemed an antibiotic prescription in 2017. Heavy users were defined as the 10% with the highest excess use, that is, their recorded use minus the average use for their sex, age group and comorbidity level as estimated from a linear regression model. Comparative analyses of sociodemographic characteristics (civil status, employment status, urbanity, educational level and country of origin) of heavy users and non-heavy users were performed using logistic regression models. RESULTS: The study population consisted of 251,733 elderly individuals, who in total redeemed 573,265 prescriptions of antibiotics. Heavy users accounted for 68% of all excess use of antibiotics. In multivariable analyses, individuals with an educational level above basic schooling, non-retired, residing in an urban municipality and being born in a country outside Scandinavia all had lower odds of being a heavy user. Widowed, divorced or single individuals had higher odds of being a heavy user compared with married individuals. Relative importance analyses showed that civil status and educational level contributed considerably to the explained variance. CONCLUSIONS: This study found an association between sociodemographic characteristics and risk of being a heavy user, indicating that sociodemographic variation exists with regard to antibiotic prescribing.
RESUMEN
BACKGROUND: Staphylococcus aureus is a frequent colonizer of the human skin and mucous membranes but can also cause a variety of serious infections. Antimicrobial resistance is an increasing worldwide challenge and is mainly driven by an overuse of antimicrobials. To avoid the spread of methicillin-resistant Staphylococcus aureus (MRSA) in Denmark, the Danish Health Authority recommends decolonization treatment of MRSA carriers and their household contacts. Standard decolonization treatment includes chlorhexidine body wash and mupirocin nasal ointment, especially throat carriage is difficult to treat. The broad-spectrum antibiotic, clindamycin, is often added to the decolonization treatment, but there is currently low scientific evidence for this treatment. AIM: To investigate whether the addition of clindamycin to the standard decolonization treatment increases decolonization success in MRSA throat carriers. METHODS: A randomized, placebo-controlled, double-blinded trial, including patients ≥ 18 years, who tested MRSA positive in the throat after completing one standard decolonization treatment. All carriers included in the trial receive standard decolonization treatment and are randomized to treatment with either placebo or clindamycin capsules for 10 days. We plan to include 40 participants in each of the two treatment arms. DISCUSSION: Due to the lack of consistent scientific evidence of clindamycin's effect in MRSA decolonization and the worldwide urgent need to reduce the use of antibiotics, we judged that a 30% increase in the decolonization success rate in carriers treated with clindamycin is appropriate to justify prescribing clindamycin as part of the decolonization treatment of asymptomatic MRSA carriers. TRIAL REGISTRATION: EudraCT number 2019-002631-29.
Asunto(s)
Antiinfecciosos Locales , Staphylococcus aureus Resistente a Meticilina , Infecciones Estafilocócicas , Antibacterianos/efectos adversos , Clorhexidina , Clindamicina/efectos adversos , Humanos , Mupirocina/efectos adversos , Faringe , Infecciones Estafilocócicas/diagnóstico , Infecciones Estafilocócicas/tratamiento farmacológicoAsunto(s)
Bacterias/efectos de los fármacos , Bacterias/aislamiento & purificación , Proteínas Bacterianas/biosíntesis , Tamizaje Masivo/estadística & datos numéricos , Cirugía Plástica/efectos adversos , beta-Lactamasas/biosíntesis , Antibacterianos/farmacología , Bacterias/enzimología , Infecciones Bacterianas/diagnóstico , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/microbiología , Dinamarca , Farmacorresistencia Bacteriana Múltiple , Femenino , Humanos , Irán , Turismo Médico , Meticilina/farmacología , Pruebas de Sensibilidad Microbiana , Vancomicina/farmacologíaRESUMEN
In recent years, the incidence of invasive meningococcal disease (IMD) caused by serogroup W (SG-W) has been rising, in particular SG-W within clonal complex 11 (cc11), which has caused epidemics and is believed to cause severe and atypical IMD. This is a case report of spon-taneous bacterial peritonitis and bacteraemia caused by meningococci SG-W cc11 in a 60-year-old female with systemic lupus erythematosus in prolonged remission as her only risk factor. Antibiotic therapy was initiated at admission, and peritoneal lavage was performed. The patient recovered successfully without sequelae.
Asunto(s)
Bacteriemia/microbiología , Infecciones Meningocócicas/microbiología , Neisseria meningitidis/aislamiento & purificación , Peritonitis/microbiología , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacteriemia/epidemiología , Dinamarca/epidemiología , Femenino , Humanos , Infecciones Meningocócicas/tratamiento farmacológico , Infecciones Meningocócicas/epidemiología , Persona de Mediana Edad , Peritonitis/terapiaRESUMEN
The diversity of OXA-48-like carbapenemases is continually expanding. In this study, we describe the dissemination and characteristics of a novel carbapenem-hydrolyzing class D ß-lactamase (CHDL) named OXA-436. In total, six OXA-436-producing Enterobacteriaceae isolates, including Enterobacter asburiae (n = 3), Citrobacter freundii (n = 2), and Klebsiella pneumoniae (n = 1), were identified in four patients in the period between September 2013 and April 2015. All three species of OXA-436-producing Enterobacteriaceae were found in one patient. The amino acid sequence of OXA-436 showed 90.4 to 92.8% identity to the amino acid sequences of other acquired OXA-48-like variants. Expression of OXA-436 in Escherichia coli and kinetic analysis of purified OXA-436 revealed an activity profile similar to that of OXA-48 and OXA-181, with activity against penicillins, including temocillin; limited or no activity against extended-spectrum cephalosporins; and activity against carbapenems. The blaOXA-436 gene was located on a conjugative â¼314-kb IncHI2/IncHI2A plasmid belonging to plasmid multilocus sequence typing sequence type 1 in a region surrounded by chromosomal genes previously identified to be adjacent to blaOXA genes in Shewanella spp. In conclusion, OXA-436 is a novel CHDL with functional properties similar to those of OXA-48-like CHDLs. The described geographical spread among different Enterobacteriaceae and the plasmid location of blaOXA-436 illustrate its potential for further dissemination.
Asunto(s)
Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Infecciones por Enterobacteriaceae/microbiología , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/genética , beta-Lactamasas/genética , beta-Lactamasas/metabolismo , Carbapenémicos/farmacocinética , Dinamarca , Enterobacteriaceae/aislamiento & purificación , Humanos , Hidrólisis , Pruebas de Sensibilidad Microbiana , Plásmidos/genéticaAsunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/genética , Enterococcus faecalis/genética , Infecciones por Bacterias Grampositivas/microbiología , Enterococos Resistentes a la Vancomicina/genética , Vancomicina/farmacología , Dinamarca/epidemiología , Enterococcus faecalis/efectos de los fármacos , Infecciones por Bacterias Grampositivas/epidemiología , Hospitales , Humanos , Filogenia , Enterococos Resistentes a la Vancomicina/efectos de los fármacos , Secuenciación Completa del GenomaRESUMEN
In Denmark, the incidence of carbapenemase-producing organisms (CPO) is increasing, and a coordinated national strategy is needed. We describe a case story of a 40-year-old woman transferred to a Danish hospital with severe complications after cosmetic surgery in the Middle East. She had an intra-abdominal infection with three different CPO, one of them co-resistant to colistin, one of the few remaining antibiotics for CPO treatment. Because of good clinical response to surgical treatment, antibiotics covering these multiresistant bacteria were not given. Isolation precautions were applied.
Asunto(s)
Proteínas Bacterianas/metabolismo , Infección Hospitalaria/microbiología , Infección de la Herida Quirúrgica/microbiología , beta-Lactamasas/metabolismo , Adulto , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Dinamarca/epidemiología , Farmacorresistencia Bacteriana Múltiple , Femenino , Humanos , Medio Oriente , Cirugía Plástica/efectos adversosRESUMEN
OBJECTIVES: In Denmark, the incidence of vancomycin-resistant Enterococcus faecium (VREfm) has increased since 2012. The aim of this study was to investigate the epidemiology and clonal relatedness of VREfm isolates in Danish hospitals in 2012-13 using WGS. The second aim was to evaluate if WGS-based typing could replace PFGE for typing of VREfm. METHODS: A population-based study was conducted including all VREfm isolates submitted for national surveillance from January 2012 to April 2013. All isolates were investigated by WGS, MLST and PFGE. RESULTS: One-hundred and thirty-two isolates were included. The majority of the isolates were from clinical samples (77%). Gastroenterology/abdominal surgery (29%) and ICUs (29%) were the predominant departments with VREfm. Genomics revealed a polyclonal structure of the VREfm outbreak. Seven subgroups of 3-44 genetically closely related isolates (separated by <17 SNPs) were identified using WGS. Direct or indirect transmission of VREfm between patients and intra- and inter-regional spreading clones was observed. We identified 10 STs. PFGE identified four major clusters (13-43 isolates) and seven minor clusters (two to three isolates). The results from the typing methods were highly concordant. However, WGS-based typing had the highest discriminatory power. CONCLUSIONS: This study emphasizes the importance of infection control measures to limit transmission of VREfm between patients. However, the diversity of the VREfm isolates points to the fact that other important factors may also affect the VREfm increase in Denmark. Finally, WGS is suitable for typing of VREfm and has replaced PFGE for typing of VREfm in Denmark.